Capital Cs Group, LLC Adamis Pharmaceuticals Corp Transaction History

Capital Cs Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 07, 2023	BUY	$0.1 - $0.3 $207 - $623	2,077 Added 2.26%	94,103 $11,000
Q4 2022 Jan 23, 2023	BUY	$0.14 - $0.22 $1,995 - $3,135	14,251 Added 18.32%	92,026 $0
Q3 2022 Oct 12, 2022	BUY	$0.24 - $0.54 $505 - $1,137	2,106 Added 2.78%	77,775 $15,000
Q2 2022 Jul 19, 2022	BUY	$0.34 - $0.57 $1,753 - $2,938	5,156 Added 7.31%	75,669 $38,000
Q1 2022 Apr 25, 2022	BUY	$0.55 - $0.73 $38,782 - $51,474	70,513 New	70,513 $40,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Capital Cs Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Cs Group, LLC with notifications on news.